MediGene
Official site for Medigene. Medigene concentrates on the development of personalized T cell immunotherapies with a focus on haematological malignancies..
Launch date
Employees
Market cap
CAD42.4m
Enterprise valuation
CAD25m (Public information from Sep 2024)
Share price
€2.32 MDG1.DE
Company register number HRB 115761 (München)
Planegg Bavaria (HQ)
Authorizing premium user...